Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiwei Liu

Showing results (471-480 of 475) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 475 results.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Haematologica|July 1, 2021
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapySeth E Karol, Deqing Pei, Colton A Smith, et al.
Blood|April 3, 2025
Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML OutcomesPatrick K Reville, Bofei Wang, Jennifer Marvin-Peek, et al.
Virulence|April 27, 2026
Characterization of the intrahepatic microbiome in patients with HBV-Related end-stage liver diseaseJiyang Chen, Tianzhu Liang, Xianbin Xu, et al.
Pageof 48

Showing results (471-480 of 475) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 475 results.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Haematologica|July 1, 2021
Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapySeth E Karol, Deqing Pei, Colton A Smith, et al.
Blood|April 3, 2025
Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML OutcomesPatrick K Reville, Bofei Wang, Jennifer Marvin-Peek, et al.
Virulence|April 27, 2026
Characterization of the intrahepatic microbiome in patients with HBV-Related end-stage liver diseaseJiyang Chen, Tianzhu Liang, Xianbin Xu, et al.
Pageof 48